Peters Anomaly

Back

Background

Peters anomaly is a rare congenital form of anterior segment dysgenesis in which abnormal cleavage of the anterior chamber occurs. It is characterized by a central corneal opacity (leukoma) due to defects in the posterior stroma, Descemet membrane, and endothelium.[1, 2, 3, 4, 5]

Peters anomaly is differentiated into 2 types: the milder type 1 Peters anomaly, which typically does not include the lens, and the more severe type 2 Peters anomaly, in which the lens adheres to the cornea (keratolenticular adhesions).[1] Peters anomaly may also be associated with systematic abnormalities.[6, 7]

Genetic mutations within FOXC1, PAX6, PITX2, and CYP1B1 can all result in abnormal neural crest cell migration to the posterior cornea, which can lead to Peters anomaly.[2, 7, 8, 9]

Pathophysiology

Peters anomaly type 1 presents with central or paracentral corneal opacity and iridocorneal adhesions. Keratolenticular adhesions are absent in this type, although the lens may be cataractous.

Peters anomaly type 2 is commonly associated with a denser corneal opacification. It presents with keratolenticular adhesions.

Peters anomaly is bilateral in 60%-80% of cases.[10] It may be associated with other abnormalities of the eye, including congenital glaucoma, myopia, aniridia, iris coloboma, microphthalmos, persistent hyperplasia of primary vitreous (PHPV), and optic disc hypoplasia.[11, 12]

Systemic associations with Peters anomaly include trisomy 13-15, partial deletion of chromosome arm 11q, and Norrie disease. Peters plus syndrome is characterized by cleft lip or palate, short stature, facial dysmorphism, genitourinary abnormalities, syndactyly, brachycephaly, and cardiac, neural, and hearing abnormalities.[6, 13]

Epidemiology

Freqency 

United States

The incidence of Peters anomaly in the United States is estimated to be 44-60 cases annually.[14]

International

The incidence of Peters anomaly outside the United States is unknown.

Mortality/Morbidity

In addition to corneal opacity and cataract, glaucoma and deprivation amblyopia may increase morbidity.[13]

The risk of mortality may be increased because of other systemic involvement, especially cardiac and neural abnormalities.[6, 13]

Race

Peters anomaly has no known racial predilection.

Sex

Peters anomaly has no known sexual predilection.

Age

Peters anomaly manifests in utero during the first trimester of pregnancy (10-16 weeks' gestation) and is therefore noted at birth. The anterior segment is formed completely by the 10th week of gestation, and, by the 16th week, most of the Descemet membrane is formed.

Prognosis

The visual prognosis in individuals with Peters anomaly is guarded. The earlier the keratoplasty is performed, the better the chance of preventing deprivation amblyopia. However, keratoplasty is often challenging to perform in infants and young children. The visual acuity in patients after keratoplasty was 20/80 or worse in most series. The likelihood that patients maintain a clear graft was also quite low at 10 years. Patients with glaucoma and cataract had a worse visual prognosis.

Penetrating keratoplasty has a success rate of 22%-83% in patients with Peters anomaly.[2]

Prognosis depends on the severity of the disease.[5]

Peters anomaly type 1 has a significantly higher rate of a clear graft than does type 2.

Patients with glaucoma and cataract have a worse prognosis.

Penetrating keratoplasty should be performed before age 12 months.

Morbidity and mortality depends on concomitant systemic anomalies.

Patient Education

Children with Peters anomaly require special educational needs depending on the visual acuity. A low-vision specialist should evaluate these children. Patients may need special equipment (loupes, binoculars, other low vision aids) depending on the visual potential.

History

Because the ocular abnormalities of Peters anomaly are noted at birth, the obstetrician or the pediatrician is often the first to observe them. The child may be completely asymptomatic or may have other ocular or systemic anomalies.

Physical

Central, paracentral, or complete corneal opacity (leukoma) is always present in patients with Peters anomaly. The size and density of the leukoma vary. Usually, no vascularization of this opacity occurs, which helps in distinguishing it from other causes of congenital corneal opacity.[15, 16, 17] The corneal periphery is usually more lucent.

Eighty percent of type 1 Peters anomaly cases are bilateral. Central or paracentral corneal opacity is present. The surrounding peripheral cornea may be clear or edematous because of glaucoma. The cornea is avascular. Iris strands often extend across the anterior chamber to the posterior surface of the cornea. These may be filamentous or thick strands or sheets. The opacity is caused by a defect in the underlying corneal endothelium and the Descemet membrane. The lens may be clear or cataractous.[6]

Type 2 Peters anomaly is characterized by adhesions between the lens and the cornea. Cases are usually bilateral. The corneal opacity is denser and may be central or eccentric. The lens is usually cataractous and typically is juxtaposed to the cornea. The posterior stroma, the Descemet membrane, and the endothelium are defective. Iris strands may or may not be present. Other ocular and systemic abnormalities are more common in type 2 than in type 1.

Bilateral Peters anomaly has a stronger association with systemic malformations than does unilateral Peters anomaly.[2]

Other ocular abnormalities

Peters anomaly may be associated with microcornea, cornea plana, sclerocornea aniridia, and glaucoma due to dysgenesis of the angle[18] . Glaucoma occurs in up to 90% of cases. Colobomas of the iris and the choroid, as well as PHPV, have been reported. Optic nerve hypoplasia or atrophy also can occur. One case of Goldenhar syndrome with Peters anomaly has been reported.[19]

Systemic abnormalities

Peters anomaly is seen in trisomy 13-15, ring chromosome 21,[20] Norrie disease, partial deletion of chromosome arm 11q, mosaic trisomy 9, and 49XXXXY syndrome.

Systemic associations in Peters anomaly include developmental delay, congenital heart disease, structural defects of the neurologic system, spinal defects, genitourinary abnormalities, external ear abnormalities, hearing loss, cleft lip and palate, and short stature.

Krause-Kivlin syndrome

Krause-Kivlin syndrome is an autosomal-recessive condition characterized by Peters anomaly, short stature, facial dysmorphism, developmental delay, and delayed skeletal maturation.[21]

Other associated abnormalities

Peters anomaly may also be associated with brachycephaly, brain malformation, cardiac anomalies, genitourinary anomalies, syndactyly, cleft lip and palate, and hearing abnormalities.[22, 23, 24, 25]

Causes

The cause of Peters anomaly is unknown; it may be caused by genetic factors, environmental factors, or both. The critical event must occur in the first trimester of pregnancy during the formation of the anterior chamber.

Most cases of Peters anomaly are sporadic; however, the literature has described autosomal-recessive pedigrees and rare autosomal-dominant pedigrees.

Mutations in FOXC1, PAX6, or PITX2 can cause Peters anomaly. The FOXC1, PAX6, and PITX2 genes are all homeobox genes that are involved in the development of the anterior segment of the eyes.[26]

Mutations in the CYP1B1 gene can also cause Peters anomaly. The CYP1B1 gene provides instructions for making an enzyme active in the eye. The role of the enzyme is unclear; however, it is likely involved in the development of the anterior segment.[27]

The RIEG1 gene is associated with Reiger syndrome. This gene is located on band 4q25. A case of Peters anomaly has been reported with this gene mutation.[9]

Another case of Peters anomaly was associated with abnormal centromere-chromatid apposition.[26]

Complications

Complications include amblyopia and decreased vision or blindness from glaucoma.

Laboratory Studies

Peters anomaly is a clinical diagnosis. Depending on the physical examination, laboratory studies may be warranted.

Imaging Studies

The following imaging studies may be performed based on the clinical findings from the physical examination:

Ocular ultrasonography

Ocular ultrasonography is a useful tool to help diagnose Peters anomaly and to differentiate it from other causes of corneal opacity.

Ocular ultrasonography is also helpful in assessing associated anterior segment abnormalities.[29]

Ocular ultrasonography shows hypoechogenicity of the anterior stroma that histopathologically correlates with the absence of the Bowman layer and the presence of stromal edema.[29]

Ultrasound biomicroscopy

Ultrasound biomicroscopy (UBM) is a type of ultrasonography that provides detailed information about the anterior segment of the eye and can visualize iridocorneal and lenticular-corneal adhesions that may be seen in Peters anomaly.

Topical endoscopic imaging

Topical endoscopic imaging (TEI) is a method used to examine the anterior segment using an otoscope through a small clear area of cornea.[30]

Infrared anterior segment camera

An infrared anterior segment camera is a tool used to observe the iris and its relation to the cornea. The mobility of the camera is useful in infants, although the resolution of the imaging may be too low in some cases.[31]

Other Tests

Additional testing should be performed if Peters plus syndrome is suspected or if there is concern for systemic associations.

Hearing tests

Hearing tests may be performed to rule out hearing abnormalities.

MRI

MRI of the brain and the spinal cord are indicated to rule out neurologic defects.

MRI of the abdomen is indicated to rule out genitourinary abnormalities.

Echocardiography

Echocardiography (ECHO) is indicated to rule out cardiac defects.

Procedures

A thorough ocular examination may be performed under anesthesia. Any clinical manifestations and systemic abnormalities must be determined before any procedure is performed under anesthesia.[13]  Associated abnormalities, including a difficult airway or congenital heart disease, will affect anesthesia management.

External photography, ocular ultrasonography (see Imaging Studies), intraocular pressure assessment, and retinoscopy may also be performed.

Histologic Findings

Histopathology is often diagnostic. Histologic findings show either thinning or absence of the Descemet membrane or the endothelium. The lens may be normal, or it may be cataractous and adhere to the cornea. The stromal lamellae are irregular and more closely packed. Undifferentiated iris strands attach to the posterior surface of the cornea.[32]

Histochemical studies have shown absence of keratan sulfate in both the cornea and the sclera.[33]

Immunohistochemical studies have shown increased amounts of fibronectin and type VI collagen in the corneas of patients with Peters anomaly.[33, 34]

Medical Care

General

In a child suspected of having Peters anomaly, a thorough physical examination by a pediatrician is warranted.

Genetic counseling must be offered as needed.

Ocular

Glaucoma is very common in patients with Peters anomaly, occurring in up to 90% of cases.

Topical medications or surgery may be necessary to control elevated intraocular pressure (IOP).

Surgical Care

Peripheral optical iridectomy

Peripheral optical iridectomy may be performed in patients with a clear peripheral cornea..

Penetrating keratoplasty

Penetrating keratoplasty is recommended in patients with bilateral visually disabling corneal opacity. To prevent amblyopia, the surgery should be performed at age 2-12 months.

Peters anomaly type 1 has a significantly higher rate of graft clarity (80%) than type 2 (20%).[2]

Intense postoperative care, consisting of frequent follow-up visits, high-dose topical corticosteroids, and early suture removal, is necessary.[1]

In patients with unilateral Peters anomaly, the decision whether to perform a penetrating keratoplasty or observe is challenging and must be made after a comprehensive discussion between the family and ophthalmologists, weighing the risks of transplantation (rejection, infection, permanent vision loss) versus the risks of Peters anomaly (usually, dense amblyopia).

Lensectomy/vitrectomy

Lensectomy/vitrectomy is indicated in patients with cataract. If left aphakic, these patients will require aphakic contact lenses or aphakic spectacles.

Filtration surgery, cryoablation, or tube shunt

Filtration surgery, cryoablation, or a tube shunt may be required in patients with glaucoma whose increased intraocular pressure cannot be managed with medications.[35]

Pupil dilatation or iridectomy

Pupil dilatation or iridectomy can be performed to optimize visual function in patients with small corneal opacity.[2]

Consultations

See the list below:

Complications

Complications of corneal transplantation and cataract surgery are numerous, especially in children.

Further Outpatient Care

An ophthalmologist should provide regular follow-up care to monitor the status of the cornea and glaucoma.

A pediatrician should monitor patients with Peters anomaly for other congenital anomalies.

Patients should receive visual rehabilitation as needed.

A pediatric contact lens specialist should fit patients with aphakic contact lenses if the natural lens is removed.

Aggressive amblyopia therapy should be performed to aid with good visual acuity. 

Inpatient & Outpatient Medications

Medications may be indicated for glaucoma and postgraft treatment.

Author

Danielle Trief, MD, Assistant Professor of Ophthalmology, Columbia University College of Physicians and Surgeons

Disclosure: Nothing to disclose.

Coauthor(s)

Sara K Schroder, Barnard College

Disclosure: Nothing to disclose.

Specialty Editors

Francisco Talavera, PharmD, PhD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Christopher J Rapuano, MD, Professor, Department of Ophthalmology, Sidney Kimmel Medical College of Thomas Jefferson University; Director of the Cornea Service, Co-Director of Refractive Surgery Department, Wills Eye Hospital

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cornea Society, AAO, OMIC, Avedro; Bio-Tissue; GSK, Kala, Novartis; Shire; Sun Ophthalmics; TearLab<br/>Serve(d) as a speaker or a member of a speakers bureau for: Avedro; Bio-Tissue; Shire<br/>Received income in an amount equal to or greater than $250 from: AAO, OMIC, Avedro; Bio-Tissue; GSK, Kala, Novartis; Shire; Sun Ophthalmics; TearLab.

Chief Editor

Donny W Suh, MD, FAAP, Chief of Pediatric Ophthalmology and Strabismus, Children's Hospital and Medical Center; Associate Professor, Department of Ophthalmology and Visual Sciences, Truhlsen Eye Institute, University of Nebraska Medical Center

Disclosure: Nothing to disclose.

Additional Contributors

Brian A Phillpotts, MD,

Disclosure: Nothing to disclose.

Guruswami Giri, MD, FRCS, Vitreo-Retinal Surgeon, Sacramento, CA

Disclosure: Nothing to disclose.

Acknowledgements

The authors and editors of Medscape Reference gratefully acknowledge the assistance of Ryan I Huffman, MD, with the literature review and referencing for this article.

References

  1. Zaidman GW, Flanagan JK, Furey CC. Long-term visual prognosis in children after corneal transplant surgery for Peters anomaly type I. Am J Ophthalmol. 2007 Jul. 144(1):104-108. [View Abstract]
  2. Bhandari R, Ferri S, Whittaker B, Liu M, Lazzaro DR. Peters anomaly: review of the literature. Cornea. 2011 Aug. 30(8):939-44. [View Abstract]
  3. Kim M, Lee SC, Lee SJ. Spontaneous corneal perforation in an eye with Peters' anomaly. Clin Ophthalmol. 2013. 7:1535-7. [View Abstract]
  4. Yang LL, Lambert SR, Drews-Botsch C, Stulting RD. Long-term visual outcome of penetrating keratoplasty in infants and children with Peters anomaly. J AAPOS. 2009 Apr. 13(2):175-80. [View Abstract]
  5. Chang JW, Kim JH, Kim SJ, Yu YS. Long-term clinical course and visual outcome associated with Peters' anomaly. Eye (Lond). 2012 Sep. 26(9):1237-42. [View Abstract]
  6. Sault RW, Sheridan J. Peter' anomaly. Ophthalmol Eye Dis. 2013 Feb. 13(5):1-3. [View Abstract]
  7. Hashemi H, Ghaffari R, Mohebi M. Posterior lamellar keratoplasty (DSAEK) in Peters anomaly. Cornea. 1201-5. 31(10):2012 Oct. [View Abstract]
  8. Dahl E, Koseki H, Balling R. Pax genes and organogenesis. Bioessays. 1997 Sep. 19(9):755-65. [View Abstract]
  9. Doward W, Perveen R, Lloyd IC, Ridgway AE, Wilson L, Black GC. A mutation in the RIEG1 gene associated with Peters' anomaly. J Med Genet. 1999 Feb. 36(2):152-5. [View Abstract]
  10. Krachmer JH, Mannis MJ, & Holland EJ. Cornea. 3. St. Louis: Mosby; 2011.
  11. Gondhowiardjo TD, van Haeringen NJ. Corneal aldehyde dehydrogenase, glutathione reductase, and glutathione S-transferase in pathologic corneas. Cornea. 1993 Jul. 12(4):310-4. [View Abstract]
  12. Kivlin JD, Apple DJ, Olson RJ, Manthey R. Dominantly inherited keratitis. Arch Ophthalmol. 1986 Nov. 104(11):1621-3. [View Abstract]
  13. M Senthilkumar , V D, Punj J, Pandey R. Peters' anomaly - anaesthetic management. Indian J Anaesth. 2009 Aug. 53(4):501-3. [View Abstract]
  14. Kurilec J, Zaidman GW. Incidence of Peters anomaly and congenital corneal opacities interfering with vision in the United States. Cornea. 2014 Aug. 33(8):848-50. [View Abstract]
  15. Mayer UM. Peters' anomaly and combination with other malformations (series of 16 patients). Ophthalmic Paediatr Genet. 1992 Jul. 13(2):131-5. [View Abstract]
  16. Ozeki H, Shirai S, Nozaki M, Sakurai E, Mizuno S, Ashikari M, et al. Ocular and systemic features of Peters' anomaly. Graefes Arch Clin Exp Ophthalmol. 2000 Oct. 238(10):833-9. [View Abstract]
  17. Traboulsi EI, Maumenee IH. Peters' anomaly and associated congenital malformations. Arch Ophthalmol. 1992 Dec. 110(12):1739-42. [View Abstract]
  18. Kim YW, Choi HJ, Kim MK, Wee WR, Yu YS, Oh JY. Clinical outcome of penetrating keratoplasty in patients 5 years or younger: peters anomaly versus sclerocornea. Cornea. 2013 Nov. 32(11):1432-6. [View Abstract]
  19. Ghose S, Kishore K, Patil ND. Oculoauricular dysplasia syndrome of Goldenhar and Peters' anomaly: a new association. J Pediatr Ophthalmol Strabismus. 1992 Nov. 29(6):384-6. [View Abstract]
  20. Cibis GW, Waeltermann J, Harris DJ. Peters' anomaly in association with ring 21 chromosomal abnormality. Am J Ophthalmol. 1985 Nov. 100(5):733-4. [View Abstract]
  21. Frydman M, Weinstock AL, Cohen HA, Savir H, Varsano I. Autosomal recessive Peters anomaly, typical facial appearance, failure to thrive, hydrocephalus, and other anomalies: further delineation of the Krause-Kivlin syndrome. Am J Med Genet. 1991 Jul. 40(1):34-40. [View Abstract]
  22. Hennekam RC, Van Schooneveld MJ, Ardinger HH, Van Den Boogaard MJ, Friedburg D, Rudnik-Schoneborn S, et al. The Peters'-Plus syndrome: description of 16 patients and review of the literature. Clin Dysmorphol. 1993 Oct. 2(4):283-300. [View Abstract]
  23. Thompson EM, Winter RM, Baraitser M. Kivlin syndrome and Peters'-Plus syndrome: are they the same disorder?. Clin Dysmorphol. 1993 Oct. 2(4):301-16. [View Abstract]
  24. Reis LM1, Tyler RC, Abdul-Rahman O, Trapane P, Wallerstein R, Broome D, et al. Mutation analysis of B3GALTL in Peters Plus syndrome. Am J Med Genet A. 2008 Oct 15. 146A(20):2603-10. [View Abstract]
  25. Heinonen TY, Maki M. Peters'-plus syndrome is a congenital disorder of glycosylation caused by a defect in the beta1,3-glucosyltransferase that modifies thrombospondin type 1 repeats. Ann Med. 2009. 1(2):2-10. [View Abstract]
  26. Wertelecki W, Dev VG, Superneau DW. Abnormal centromere-chromatid apposition (ACCA) and Peters' anomaly. Ophthalmic Paediatr Genet. 1985 Aug. 6(1-2):247-55. [View Abstract]
  27. Peters Anomaly. US National Library of Medicine. Available at https://ghr.nlm.nih.gov/condition/peters-anomaly#resources. 2016 Aug 16; Accessed: June 2016.
  28. Krachmer JH, Rodrigues MM. Posterior keratoconus. Arch Ophthalmol. 1978 Oct. 96(10):1867-73. [View Abstract]
  29. Nischal KK, Naor J, Jay V, MacKeen LD, Rootman DS. Clinicopathological correlation of congenital corneal opacification using ultrasound biomicroscopy. Br J Ophthalmol. 2002 Jan. 86(1):62-9. [View Abstract]
  30. Hirata A, Mine T. A simple and easy method using rigid endoscope to detect iridocorneal and keratolenticular adhesions in peters' anomaly. Case Rep Ophthalmol. 2013 Nov 06. 4(3):238-42. [View Abstract]
  31. Morishige N, Yamada N, Morita Y, Sonoda KH. Peters' anomaly imaged with an infrared anterior segment camera. Clin Experiment Ophthalmol. 2014 May-Jun. 42(4):391-2. [View Abstract]
  32. Matsubara A, Ozeki H, Matsunaga N, Nozaki M, Ashikari M, Shirai S, et al. Histopathological examination of two cases of anterior staphyloma associated with Peters' anomaly and persistent hyperplastic primary vitreous. Br J Ophthalmol. 2001 Dec. 85(12):1421-5. [View Abstract]
  33. Ozeki H, Shirai S, Ikeda K, Majima A, Hirabayashi Y, Yamada K. Histochemical studies on two cases of Peters' anomaly. Nippon Ganka Gakkai Zasshi. 1996 Jun. 100(6):471-7.
  34. Cameron JA. Good visual result following early penetrating keratoplasty for Peters' anomaly. J Pediatr Ophthalmol Strabismus. 1993 Mar-Apr. 30(2):109-12. [View Abstract]
  35. Almobarak F, Khan AO. Complications and 2-year valve survival following Ahmed valve implantation during the first 2 years of life. Br J Ophthalmol. 2009 Jul. 93(7):795-8. [View Abstract]
  36. Iseri SU, Osborne RJ, Farrall M, Wyatt AW, Mirza G, Nürnberg G, et al. Seeing clearly: the dominant and recessive nature of FOXE3 in eye developmental anomalies. Hum Mutat. 2009 Oct. 30(10):1376-86. [View Abstract]